Form 4: DENTSPLY SIRONA Director Buys 50,000 XRAY Shares

DENTSPLY SIRONA Director Gregory T. Lucier acquired 50,000 shares of common stock through trust transactions in early March 2026, signaling insider confidence.

Summary

• Gregory T. Lucier, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired a total of 50,000 shares of common stock.
• The shares were purchased indirectly through a trust of which Mr. Lucier serves as trustee and is a beneficiary.
• On March 2, 2026, 27,555 shares were acquired at a weighted average price of $14.245 per share.
• On March 3, 2026, an additional 22,445 shares were acquired at a weighted average price of $14.028 per share.
• Following these transactions, Mr. Lucier's indirect beneficial ownership includes 50,000 shares via the trust, 24,901.284 shares via a Family Partnership, and 21,000 shares via his IRA.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal. Significant insider buying by a director suggests a belief in the company's undervaluation or strong future prospects, which is generally well-received by investors.

Positives

• A Director's purchase of a significant number of shares (50,000) indicates strong insider confidence in the company's future prospects.
• The acquisition was made at market prices, suggesting a belief that the current valuation represents a good investment opportunity.

Industry Context

StockSavvy.ai notes that insider buying, especially by a director, often signals a positive outlook from those closest to the company's operations and strategic direction. This transaction by a DENTSPLY SIRONA director could be interpreted by the market as a vote of confidence in the company's performance and future growth within the dental equipment and consumables industry.

Related Party Transactions

• The acquisition of shares was made indirectly through a trust for which the reporting person, Gregory T. Lucier, serves as trustee and is a beneficiary. He disclaims beneficial ownership except to the extent of his pecuniary interest.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator, potentially increasing confidence in the company's stock.
• The transaction reinforces the alignment of interests between management and shareholders.

Key Dates

Recommendation

A seasoned investor would interpret a significant insider purchase by a director as a strong signal of confidence in the company's intrinsic value and future growth potential. This action suggests that the director believes the stock is currently undervalued or poised for appreciation, making it an opportune time to buy.

Keywords

DENTSPLY SIRONA, XRAY, Insider Buying, Form 4, Director Purchase, Stock Acquisition, Beneficial Ownership, Dental Industry